West Pharmaceutical Services | Les Charges D'Exploitation



Operating Expenses Changement Date
Align Technology USD 851.07M 35.5M 2024-12
Avanos Medical USD 598.1M 439.7M 2024-12
Baxter International USD 3.19B 644M 2024-12
Becton, Dickinson and Co. USD 4.72B 74M 2024-12
Charles River Laboratories USD 1.17B 277.88M 2024-12
Cooper Companies USD 782.7M 37.3M 2025-01
Dentsply International USD 1.41B 1000K 2024-12
Haemonetics USD 289.51M 4.3M 2024-12
ICU Medical USD 592.11M 11.22M 2024-12
Insulet USD 488.2M 32.4M 2024-12
Integra LifeSciences USD 407.42M 18.45M 2024-12
IQVIA Holdings USD 3.33B 14M 2024-12
J&J USD 18.63B 500M 2024-12
Medtronic USD 6.65B 162M 2025-01
Merit Medical Systems USD 318.59M 16.01M 2024-12
Neogen USD 688.74M 474.04M 2024-11
Quidel USD 808.2M 96.1M 2024-12
Repligen USD 162.7M 10.11M 2024-09
Solventum Corp 1.94B 131M 2024-12
STAAR Surgical USD 76.86M 6.05M 2024-12
Terumo JPY 217.77B 10.36B 2024-12
West Pharmaceutical Services USD 589.2M 3.6M 2024-12



West Pharmaceutical Services Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.